90 related articles for article (PubMed ID: 10215497)
1. Prognostic score for Hodgkin's disease.
Watine J
N Engl J Med; 1999 Apr; 340(16):1289-90. PubMed ID: 10215497
[No Abstract] [Full Text] [Related]
2. Prognostic factors in advanced Hodgkin's disease--can they guide therapeutic decisions?
Brice P
N Engl J Med; 1998 Nov; 339(21):1547-9. PubMed ID: 9819456
[No Abstract] [Full Text] [Related]
3. [Mediastinal Hodgkin's disease and non-Hodgkin lymphoma in childhood].
Kuleva SA
Vopr Onkol; 2002; 48(6):735-7. PubMed ID: 12530278
[TBL] [Abstract][Full Text] [Related]
4. Prognostic score for Hodgkin's disease.
Jack FR; Angus B; Taylor PR
N Engl J Med; 1999 Apr; 340(16):1288-9; author reply 1289-90. PubMed ID: 10215496
[No Abstract] [Full Text] [Related]
5. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
6. [Erythrocyte sedimentation rate].
Kumasaka K
Nihon Rinsho; 2004 Dec; 62 Suppl 12():564-6. PubMed ID: 15658390
[No Abstract] [Full Text] [Related]
7. [Principles of determining reference values in hematology].
Berger J
Vnitr Lek; 1990 Mar; 36(3):287-91. PubMed ID: 2353475
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy.
Smith RS; Chen Q; Hudson MM; Link MP; Kun L; Weinstein H; Billett A; Marcus KJ; Tarbell NJ; Donaldson SS
J Clin Oncol; 2003 May; 21(10):2026-33. PubMed ID: 12743158
[TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of soluble HLA-I and beta2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease.
Albitar M; Vose JM; Johnson MM; Do KA; Day A; Jilani I; Kantarjian H; Keating M; O'Brien SM; Verstovsek S; Armitage JO; Giles FJ
Leuk Res; 2007 Feb; 31(2):139-45. PubMed ID: 16545870
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of serum albumin in Hodgkin's disease.
Gobbi PG; Cavalli C; Gendarini A; Bonfichi M; Galeone F; Inzoli A; Ascari E
Haematologica; 1986; 71(2):95-102. PubMed ID: 3087839
[No Abstract] [Full Text] [Related]
11. Low acute hematological toxicity during chemotherapy predicts reduced disease control in advanced Hodgkin's disease.
Brosteanu O; Hasenclever D; Loeffler M; Diehl V;
Ann Hematol; 2004 Mar; 83(3):176-82. PubMed ID: 15064867
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of the prognostic score for advanced Hodgkin's disease in patients with human immunodeficiency virus-associated Hodgkin's lymphoma.
Ribera JM; Navarro JT; Oriol A; Vaquero M; Grau J; Feliu E
Haematologica; 2000 Mar; 85(3):325-6. PubMed ID: 10702829
[No Abstract] [Full Text] [Related]
13. Prognosis in Hodgkin's disease: verification of a new predictive equation.
Bettini R; Quadrelli M; Quadrelli G; Biganzoli L; Venco A
Haematologica; 1990; 75(5):482. PubMed ID: 2097268
[No Abstract] [Full Text] [Related]
14. Comment: how shall we look at Hodgkin's disease?
Kline IK
Lymphology; 1969 Mar; 2(1):27-9. PubMed ID: 5772224
[No Abstract] [Full Text] [Related]
15. Hodgkin's disease.
Hartsock RJ
Pa Med; 1972 Jul; 75(7):69. PubMed ID: 5032314
[No Abstract] [Full Text] [Related]
16. Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease: potential for a prognostic factor.
Weihrauch MR; Manzke O; Beyer M; Haverkamp H; Diehl V; Bohlen H; Wolf J; Schultze JL
Cancer Res; 2005 Jul; 65(13):5516-9. PubMed ID: 15994922
[TBL] [Abstract][Full Text] [Related]
17. State-of-the-art therapeutics: Hodgkin's lymphoma.
Connors JM
J Clin Oncol; 2005 Sep; 23(26):6400-8. PubMed ID: 16155026
[TBL] [Abstract][Full Text] [Related]
18. Plasma cytokine and soluble receptor signature predicts outcome of patients with classical Hodgkin's lymphoma: a study from the Groupe d'Etude des Lymphomes de l'Adulte.
Casasnovas RO; Mounier N; Brice P; Divine M; Morschhauser F; Gabarre J; Blay JY; Voillat L; Lederlin P; Stamatoullas A; Bienvenu J; Guiguet M; Intrator L; Grandjean M; Brière J; Ferme C; Salles G;
J Clin Oncol; 2007 May; 25(13):1732-40. PubMed ID: 17389336
[TBL] [Abstract][Full Text] [Related]
19. Angiogenic molecules in Hodgkin's disease: results from sequential serum analysis.
Passam FH; Alexandrakis MG; Moschandrea J; Sfiridaki A; Roussou PA; Siafakas NM
Int J Immunopathol Pharmacol; 2006; 19(1):161-70. PubMed ID: 16569354
[TBL] [Abstract][Full Text] [Related]
20. The management of Hodgkin's disease.
Lister A
Cancer Treat Rev; 1999 Jun; 25(3):157-9. PubMed ID: 10425257
[No Abstract] [Full Text] [Related]
[Next] [New Search]
